Indeed, the survival analysis showed that all of the 4T1/TGF-β1 tumor-bearing mice without any treatment died at day 45 after tumor cell injection, while the 4T1/RFP tumor-bearing mice without treatment displayed an increased life span (P = 0.007) (Fig. 2c). This evidence concerns the gene TGFB1 and neoplasm.